Correlation between Serum Zinc Levels and Levodopa in Parkinson's Disease

被引:10
作者
Matsuyama, Hirofumi [1 ]
Matsuura, Keita [1 ]
Ishikawa, Hidehiro [1 ]
Hirata, Yoshinori [1 ]
Kato, Natsuko [1 ]
Niwa, Atsushi [2 ]
Narita, Yugo [1 ]
Tomimoto, Hidekazu [1 ]
机构
[1] Mie Univ, Dept Neurol, Grad Sch Med, 2-174 Edobashi, Tsu, Mie 5148507, Japan
[2] Natl Mie Hosp, Dept Neurol, 357 Ohsatokubota, Tsu, Mie 5140125, Japan
关键词
zinc deficiency; zinc-chelating action; dosing frequency of levodopa; psychiatric symptom; DEPRESSION; ABSORPTION;
D O I
10.3390/nu13114114
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Long-term intake of potential zinc-chelating drugs may cause zinc deficiency. We postulated that zinc deficiency in Parkinson's disease (PD) patients was related to the intake of drugs such as levodopa. We investigated the relationship between zinc levels and levodopa administration period, dosage, and symptoms of zinc deficiency in PD patients. We measured serum zinc levels and analyzed correlations between serum zinc levels, the levodopa oral administration period, dosage, dosing frequency, and zinc deficiency symptoms including taste disorders. Data analyses were performed using Spearman's rank correlation coefficient. The mean serum zinc level was 60.5 & PLUSMN; 11.6 mu g/dL. The mean administration period for levodopa was 8.0 & PLUSMN; 5.5 years, mean administration frequency 3.4 & PLUSMN; 0.9 times/d, and mean administration dose 420.6 & PLUSMN; 237.1 mg/d. Negative correlations between zinc levels and levodopa dosage and dosing frequency were found. Multiple regression analysis showed a significant correlation with the frequency of levodopa (beta = -0.360, p = 0.007). No significant change in clinical symptoms was observed after zinc administration, but anxiety tended to improve. Our results indicated that frequent levodopa administration strongly influenced serum zinc levels which may have alleviating effects on psychiatric symptoms; therefore, preventing zinc deficiency can be important during PD treatment.
引用
收藏
页数:8
相关论文
共 50 条
[21]   Relationship between the severity of olfactory dysfunction and serum zinc levels [J].
Hirotaka Tanaka ;
Eri Mori ;
Rumi Sekine ;
Nagomi Yonezawa ;
Masayoshi Tei ;
Nobuyoshi Otori .
European Archives of Oto-Rhino-Laryngology, 2023, 280 :3229-3236
[22]   Relationship between the severity of olfactory dysfunction and serum zinc levels [J].
Tanaka, Hirotaka ;
Mori, Eri ;
Sekine, Rumi ;
Yonezawa, Nagomi ;
Tei, Masayoshi ;
Otori, Nobuyoshi .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (07) :3229-3236
[23]   The correlation of depression with functional activity in Parkinson’s disease [J].
Chia-Yih Liu ;
Shuu-Jiun Wang ;
Jong-Ling Fuh ;
Cheng-Huai Lin ;
Yong-Yi Yang ;
H.-C. Liu .
Journal of Neurology, 1997, 244 :493-498
[24]   The correlation of depression with functional activity in Parkinson's disease [J].
Liu, CY ;
Wang, SJ ;
Fuh, JL ;
Lin, CH ;
Yang, YY ;
Liu, HC .
JOURNAL OF NEUROLOGY, 1997, 244 (08) :493-498
[25]   Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson's Disease [J].
Galli, Emilia ;
Planken, Anu ;
Kadastik-Eerme, Liis ;
Saarma, Mart ;
Taba, Pille ;
Lindholm, Paivi .
FRONTIERS IN NEUROSCIENCE, 2019, 13
[26]   Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease [J].
Paula Scalzo ;
Arthur Kümmer ;
Thales Lage Bretas ;
Francisco Cardoso ;
Antônio Lúcio Teixeira .
Journal of Neurology, 2010, 257 :540-545
[27]   Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease [J].
Scalzo, Paula ;
Kuemmer, Arthur ;
Bretas, Thales Lage ;
Cardoso, Francisco ;
Teixeira, Antonio Lucio .
JOURNAL OF NEUROLOGY, 2010, 257 (04) :540-545
[28]   Correlation between MDS UPDRS III with depression, anxiety, and fatigue symptoms in Parkinson's disease [J].
Hutabarat, Ervina A. J. ;
Suroto ;
Mirawati, Diah K. ;
Subandi ;
Danuaji, Rivan ;
Budianto, Pepi ;
Hambarsari, Yetty ;
Hamidi, Baarid L. ;
Prabaningtyas, Hanindia R. ;
Ristinawati, Ira ;
Tejomukti, Teddy ;
Tedjo, Andi A. ;
Putri, Ardisa P. ;
Putra, Andry N. .
JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2024, 12 :S52-S56
[29]   Acute homocysteine rise after repeated levodopa application in patients with Parkinson's disease [J].
Mueller, Thomas ;
Muhlack, Siegfried .
PARKINSONISM & RELATED DISORDERS, 2010, 16 (10) :688-689
[30]   Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD) [J].
Morrison, CE ;
Borod, JC ;
Brin, MF ;
Hälbig, TD ;
Olanow, CW .
JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (10-11) :1333-1341